Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease Read more
Chancellor needs to stop relying on selling futures and rethink economic strategy for the present Read more
Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium on Lun Read more
Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress By Investing.com Read more
NMDP BioTherapies To Present Data at ISCT 2024 on the Stability of Infectious Disease Marker Analytes During Donor Qualification for Allogeneic Cell Therapies Read more
Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention By Investing.com Read more